ArticleScientific reports2026
The microbiome of interstitial cystitis revealed by 2bRAD-M.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic, female-prone, multifactorial bladder disorder characterized by symptoms such as suprapubic pain, urinary urgency, frequency, and pelvic discomfort, often exacerbated by bladder filling and associated with urothelial dysfunction and inflammation, while the etiology of IC/BPS remains largely unknown. This study was conducted by performing 2bRAD sequencing for Microbiome (2bRAD-M) on bladder tissue samples to investigate the microbial community distribution characteristics of bladder tissues in patients with IC/BPS. The study recruited a total of 11 patients with IC/BPS. The lesion and surrounding normal tissue were collected from each patient. DNA was extracted, and the genomes of various microorganisms in the tissue were digested using IIB restriction endonucleases. The unique tags were subjected to microbial qualitative and relative quantitative analysis. A total of 118 bacteria and 2 fungi were detected in 22 samples from 11 patients diagnosed with IC/BPS. Microbial diversity was similar in bladder lesion tissue and surrounding normal tissue. The microbial composition of the bladder tissues was similar, with 3 microorganisms, namely Mycobacterium_tuberculosis, Ralstonia_sp000620465 and Klebsiella_pneumoniae, detected in all tissues. At the species level, Escherichia_coli, Bacillus_A_bombysepticus and Chlamydophila_abortus were the dominant species. 2 microorganisms (Sphingopyxis and Rhizobiaceae) were enriched in the lesion tissue, while Acetobacteraceae and Porphyromonas were enriched in the normal tissue from patients with IC/BPS. This study preliminarily depicted the microbial panorama of bladder tissues from IC/BPS patients using the 2bRAD-M technique, revealing the distribution of microorganisms associated with the disease and possible differences, providing new perspectives and research directions for subsequent studies on the pathogenesis and progression of IC/BPS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.